MorphoSys's vision

MorphoSys is committed to develop exceptional new treatments for patients suffering from serious diseases. A leader in the field of therapeutic antibodies today, MorphoSys is driven by the ambition of creating the most valuable pipeline of biopharmaceuticals in the biotechnology industry.

Events

25. Tue
September

Berenberg und Goldman Sachs 7th German Corporate Conference

Munich, Germany
28. Fri
September

Leerink Partners Healthcare Summit

Meadowood Napa Valley, CA, USA
03. Wed
October

Leerink Round Table Rare-Diseases & Immuno-Oncology

NYC, USA

Presentations

06/20/2018
JMP Securities Life Sciences Conference
06/06/2018
dbAccess Berlin
Berlin, Germany
05/21/2018
UBS Global Healthcare Conference
New York, US
05/03/2018
Q1 Call Presentation
03/13/2018
Year-End Results 2017
Planegg, Deutschland

Corporate Communications and Investor Relations
Phone: +49 89 89927 404
Fax: +49 89 89927 5404
Email Contact